IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CRBP

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents23.3725.6628.4926.9820.0418.9017.2019.4223.6914.1013.7211.258.357.3217.0012.4425.7757.0325.0137.12
Short-term Investments94.57112.56134.7877.0096.55113.89131.86139.94123.34106.007.1817.4828.2236.9042.1953.7947.5329.0972.6469.74
Total Current Assets122.75143.57166.95107.57122.83137.36152.98160.89148.31121.7023.5531.2138.2745.8660.1867.3575.2488.48100.20111.67
Property, Plant & Equipment0.070.120.160.200.250.300.390.520.670.820.971.121.271.431.611.801.992.212.392.65
Total Non-current Assets*4.240.911.241.942.262.572.903.283.674.054.735.085.455.786.136.486.837.207.537.91
Total Assets126.99144.48168.20109.51125.09139.93155.88164.17151.98125.7428.2736.2843.7251.6566.3173.8382.0795.68107.73119.57
Accounts Payable5.250.442.222.743.994.074.792.891.152.083.184.711.511.322.171.371.992.701.782.55
Total Current Liabilities21.4818.1420.6917.0613.3311.6211.8211.6323.9825.9231.8931.5416.3914.3612.6417.4715.6315.1217.0117.14
Long-term Debt------------------0.0017.8920.0320.7221.5921.5921.1921.1921.1921.1921.19
Total Non-current Liabilities*3.270.000.000.310.761.211.632.052.462.863.284.4317.8220.8320.6814.4216.9719.4021.6124.80
Total Liabilities24.7518.1420.6917.3714.0912.8313.4513.6726.4428.7835.1835.9734.2035.1933.3231.8832.6034.5238.6241.95
Retained Earnings(613.44)(578.40)(555.43)(534.87)(511.53)(493.87)(476.89)(467.36)(453.58)(443.58)(436.68)(428.66)(418.61)(409.83)(392.08)(381.20)(372.42)(359.17)(349.73)(339.47)
Total Stockholder Equity102.24126.34147.5092.15110.99127.11142.43150.50125.5496.97(6.90)0.319.5216.4632.9941.9549.4761.1669.1177.63
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue----------------------------0.000.00--0.000.000.10
Research & Development31.1819.8218.4120.8615.1915.648.7910.816.875.766.986.554.2513.396.244.112.503.2914.088.70
Selling, General & Admin5.014.493.563.563.974.133.824.704.123.863.122.943.943.914.554.074.845.239.295.28
Total Operating Expenses36.1924.3021.9724.4219.1519.7712.6115.5110.999.6210.109.498.1917.3010.808.1812.348.5210.0013.97
Operating Income(36.19)(24.30)(21.97)(24.42)(19.15)(19.77)(12.61)(15.50)(10.99)(9.62)(10.10)(9.49)(8.19)(17.30)(10.80)(8.18)(12.34)(8.52)(10.00)(13.88)
Interest Expense----------------0.65----------------------
Net Income(35.04)(22.97)(20.55)(23.34)(17.66)(16.98)(9.53)(13.78)(10.00)(6.90)(8.02)(10.05)(8.78)(17.74)(10.88)(8.78)(13.25)(9.44)(10.26)(2.18)
Basic EPS(1.81)(1.23)(1.17)(1.90)(1.44)(1.39)(0.80)(1.15)(0.90)(0.83)(1.75)(2.27)(2.05)(4.24)(9.89)(0.07)(0.11)(0.08)(0.08)(0.02)
Diluted EPS(1.81)(1.23)(1.17)(1.90)(1.44)(1.39)(0.80)(1.15)(0.90)(0.83)(5.85)(2.27)2.05(4.24)(9.90)(0.07)--------
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(29.63)(25.57)(15.92)(15.55)(16.60)(16.42)(10.94)(13.94)(8.94)(7.97)(6.01)(7.18)(7.80)(15.11)(7.45)(7.25)(12.23)(10.62)(9.70)0.86
Capital Expenditures0.010.01----------------0.000.000.000.000.000.000.000.01----
Free Cash Flow*(29.63)(25.58)----------------(6.01)(7.18)(7.80)(15.11)(7.45)(7.25)(12.23)(10.63)----
Investing Cash Flow18.2622.46(57.14)19.6417.7418.128.73(15.36)(16.44)(98.24)10.3910.908.815.5511.78(5.97)(18.70)42.96(3.18)0.28
Financing Cash Flow9.07--74.582.850.000.00(0.01)25.0434.96106.58(1.90)(0.82)0.02(0.11)0.23(0.11)(0.33)(0.33)0.77(0.10)
← Scroll for more columns →

* Derived from reported values